TITLE

73-Year-Old Man With Increasing Abdominal Girth and Dyspnea

AUTHOR(S)
REPPERT, SARA L.; WITTICH, CHRISTOPHER M.
PUB. DATE
October 2011
SOURCE
Mayo Clinic Proceedings;Oct2011, Vol. 86 Issue 10, p1002
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on nonalcoholic fatty liver disease (NAFLD), which begins with steatosis and ends with cirrhosis. It states the histologic changes in NAFLD are similar to those in alcoholic liver disease, but occurs in patients who report drinking little alcohol. It states diabetes, obesity and ethnicity influence the risk of developing NAFLD.
ACCESSION #
66616748

 

Related Articles

  • Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). Raszeja-Wyszomirska, Joanna; Szymanik, Barbara; Lawniczak, Malgorzata; Kajor, Maciej; Chwist, Alina; Milkiewicz, Piotr; Hartleb, Marek // BMC Gastroenterology;2010, Vol. 10, p67 

    Background: Nonalcoholic fatty liver disease (NAFLD) includes a wide spectrum of liver diseases, ranging from pure steatosis to nonalcoholic steatohepatitis (NASH), and eventually to liver cirrhosis with its complications. Identifying advanced fibrosis in patients is crucial to evaluating...

  • The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease. Schuck, Robert N.; Zha, Weibin; Edin, Matthew L.; Gruzdev, Artiom; Vendrov, Kimberly C.; Miller, Tricia M.; Xu, Zhenghong; Lih, Fred B.; DeGraff, Laura M.; Tomer, Kenneth B.; Jones, H. Michael; Makowski, Liza; Huang, Leaf; Poloyac, Samuel M.; Zeldin, Darryl C.; Lee, Craig R. // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Fatty liver disease is an emerging public health problem without effective therapies, and chronic hepatic inflammation is a key pathologic mediator in its progression. Cytochrome P450 (CYP) epoxygenases metabolize arachidonic acid to biologically active epoxyeicosatrienoic acids (EETs), which...

  • Light and Moderate Alcohol Consumption Significantly Reduces the Prevalence of Fatty Liver in the Japanese Male Population. Gunji, Toshiaki; Matsuhashi, Nobuyuki; Sato, Hajime; Fujibayashi, Kazutoshi; Okumura, Mitsue; Sasabe, Noriko; Urabe, Akio // American Journal of Gastroenterology;Sep2009, Vol. 104 Issue 9, p2189 

    OBJECTIVES:The effect of alcohol consumption on the liver is controversial. Recent reports have suggested that moderate alcohol consumption decreases the prevalence of elevated alanine aminotransferase levels. The role of alcohol consumption in the development of fatty liver (FL), however, has...

  • A BIRD'S EYE VIEW OF NON ALCOHOLIC FATTY LIVER DISEASE- AND INSULIN RESISTANT STATE.  // Acta Medica Saliniana;2010, Vol. 39 Issue 1, p1 

    No abstract available.

  • Editorial: Non-Alcoholic Fatty Liver Disease After Liver Transplantation: A Case of Nurture and Nature. Ong, Janus; Younossi, Zobair M. // American Journal of Gastroenterology;Mar2010, Vol. 105 Issue 3, p621 

    Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. Most patients with cryptogenic cirrhosis are considered to have had “burned out NAFLD.” Although the recurrence and progression of NAFLD after liver transplantation (LT) have been shown previously,...

  • health handbook. Adams, Penny // Good Health & Medicine;Apr2007, p18 

    The article answers a question about fatty liver. Fatty liver refers to abnormal build-up of fat in liver cells and the problems causing this are excess alcohol, obesity and type 2 diabetes. It is important to treat the causes of fatty liver and avoid alcohol, as severe cases may progress to...

  • Lipid-Lowering Agents in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Human Studies. Nseir, William; Mograbi, Julnar; Ghali, Murad // Digestive Diseases & Sciences;Jul2012, Vol. 57 Issue 7, p1773 

    Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease which refers to the presence of hepatic steatosis without significant intake of alcohol. NAFLD is an asymptomatic disease that can progress to nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular...

  • New wine in old bottle: liver and diabetes. Sridhar, G.; Rao, P. // International Journal of Diabetes in Developing Countries;Sep2013, Vol. 33 Issue 3, p131 

    The authors reflect on the association between liver disease and diabetes mellitus. They note that people with nonalcoholic fatty liver disease (NAFLD) have a higher prevalence of metabolic syndrome and lower levels of [25-(OH)D [9], based on a study. They cite several hypotheses on the...

  • Enfermedad grasa del hígado no alcohólica en pacientes con diabetes mellitus 2. Isidro Minero-Alfaro, José; López, Helena Martínez // Revista de Sanidad Militar;ene/feb2007, Vol. 61 Issue 1, p6 

    Introduction. The nonalcoholic fatty liver disease (NAFLD) includes so much the steatosis (fatty liver) as the nonalcoholic steatohepatitis (NASH), recently has been increased their importance in recognizing it like a condition that potentially provides chronic hepatic damage. Objective. To...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics